Published in
Springer (part of Springer Nature), Supportive Care in Cancer, 3(24), p. 1285-1294
DOI: 10.1007/s00520-015-2907-2
Links
Tools
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial
Journal article published in 2015 by
Matteo Lambertini,
Paolo Bruzzi,
Francesca Poggio 
,
Simona Pastorino,
Giovanni Gardin,
Matteo Clavarezza,
Claudia Bighin,
Paolo Pronzato,
Lucia Del Mastro
,
Simona Pastorino,
Giovanni Gardin,
Matteo Clavarezza,
Claudia Bighin,
Paolo Pronzato,
Lucia Del Mastro
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 